Fina Biosolutions offers bioconjugation services. We are noted for our expertise in conjugate vaccines and have extensive experience in the synthesis of conjugate vaccines, including proprietary methods. Vaccines using chemistry developed by Fina Bio’s founder, Andrew Lees, have been administered to millions of children worldwide.
Fina Biosolutions protein services help biotech companies move from discovery to early clinical trials. We offer protein expression, purification and immunoassay design services.